事業提携・ライセンシング・投資・M&A動向:February 2013(製薬業界)...市場調査レポートについてご紹介

【英文タイトル】Partnerships, Licensing, Investments and M&A Deals and Trends for February 2013 in Pharmaceuticals

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 5
2 Pharmaceuticals & Healthcare, Global, Deal Summary 7
2.1 Pharmaceuticals & Healthcare, Global, Deal Analysis, February 2013 7
2.2 Pharmaceuticals & Healthcare, Global, Major Deals, February 2013 9
2.2.1 Biogen Idec to Acquire Elan’s Interest in Multiple Sclerosis Drug Tysabri for $3.2 Billion 9
2.2.2 Cardinal Health to Acquire AssuraMed for Up to $2.07 Billion 10
2.2.3 Mylan to Acquire Agila Specialties from Strides Arcolab for Up to $1.85 Billion 10
2.2.4 Quintiles Transnational Files Registration Statement for IPO to Raise Up to $600 Million 10
2.2.5 Chiasma Enters into Licensing Agreement with Roche for Octreolin 11
2.3 Pharmaceuticals & Healthcare, Global, by Type, Number of Deals, February 2013 12
2.4 Pharmaceuticals & Healthcare, Global, by Type, Deal Values, February 2013 13
3 Pharmaceuticals and Healthcare, Global, Deals, Summary, by Type 14
3.1 Pharmaceuticals & Healthcare, Global, M&A, February 2013 14
3.1.1 Top M&A Deals in February 2013 15
3.1.2 Pharmaceuticals & Healthcare, Global, M&A Deals by Therapy Area, September 2012–February 2013 16
3.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals, February 2013 17
3.2.1 Top Equity Offering Deals in February 2013 18
3.2.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals by Therapy Area, September 2012 – February 2013 19
3.3 Pharmaceuticals & Healthcare, Global, Private Equity and Venture Capital Deals, February 2013 20
3.3.1 Top PE/VC Deals in February 2013 21
3.3.2 Pharmaceuticals & Healthcare, Global, PE/VC by Therapy Area, February 2013 22
3.3.3 Pharmaceuticals & Healthcare, Global, Venture Capital Deals by Stage of Financing, February 2013 23
3.3.4 Pharmaceuticals & Healthcare, Global, Top Venture Financing Firms, September 2012 – February 2013 25
3.3.5 Pharmaceuticals & Healthcare, Global, Top VC Backed Companies, September 2012 – February 2013 26
4 Pharmaceuticals & Healthcare, Global, Partnership Deals, February 2013 27
4.1 Pharmaceuticals & Healthcare, Global, Partnership Deals, February 2013 27
4.2 Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, September 2012 – February 2013 28
4.3 Pharmaceuticals & Healthcare, Global, Partnership Deals by Upfront and Milestone Payments and Deal Values (US$ m), February 2013 29
4.3.1 Pharmaceuticals & Healthcare, Global, Top Partnership Deals by Payment Mode, February 2013 30
4.4 Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, by Upfront and Milestone Payments and Deal Values (US$ m), September 2012 – February 2013 31
4.5 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, Number Of Deals, September 2012 – February 2013 32
4.6 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, Deal Values (US$ m), September 2012 – February 2013 33
4.7 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, by Upfront & Milestone Payments and Deal Values (US$ m), September 2012 – February 2013 34
5 Pharmaceuticals & Healthcare, Global, Licensing Agreements, February 2013 35
5.1 Pharmaceuticals & Healthcare, Global, Licensing Agreements, February 2013 35
5.2 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, Upfront and Milestone Payments and Deal Values (US$ m), February 2013 36
5.2.1 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements by Deal Value, February 2013 37
5.2.2 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, by Total Upfront Payments, February 2013 37
5.2.3 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements by Total Milestone Payment, February 2013 38
5.3 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Total Deal Values (US$ m), September 2012 – February 2013 39
5.4 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Upfront Payments and Milestone Payments (US$ m), September 2012 – February 2013 40
5.5 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Total Deal Values (US$ m), September 2012 – February 2013 41
5.6 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Upfront Payments and Milestone Payments (US$ m), September 2012 – February 2013 43
6 Pharmaceuticals & Healthcare, Global, Deal Summary by Therapy Area 44
6.1 Pharmaceuticals & Healthcare, Global, Oncology Deals, February 2013 44
6.1.1 Oncology – Deals of the Month 45
6.2 Pharmaceuticals & Healthcare, Global, Central Nervous System Deals, February 2013 47
6.2.1 Central Nervous System – Deals of the Month 48
6.3 Pharmaceuticals & Healthcare, Global, Immunology Deals, February 2013 49
6.3.1 Immunology – Deal of the Month 50
6.4 Pharmaceuticals & Healthcare, Global, Infectious Disease Deals, February 2013 51
6.4.1 Infectious Diseases – Deals of the Month 52
6.5 Pharmaceuticals & Healthcare, Global, Metabolic Disorder Deals, February 2013 53
6.5.1 Metabolic Disorders – Deal of the Month 54
6.6 Pharmaceuticals & Healthcare, Global, Cardiovascular Deals, February 2013 55
6.6.1 Cardiovascular – Deal of the Month 56
6.7 Pharmaceuticals & Healthcare, Global, Respiratory, Deals, February 2013 57
6.7.1 Respiratory – Deal of the Month 58
7 Deal Summary by Geography 59
7.1 Pharmaceuticals & Healthcare, North America Deals, February 2013 59
7.1.1 North America – Deals of the Month 60
7.2 Pharmaceuticals & Healthcare, Europe, Deals, February 2013 62
7.2.1 Europe – Deals of the Month 63
7.3 Pharmaceuticals & Healthcare, Asia-Pacific, Regional Deals, February 2013 65
7.3.1 Asia-Pacific – Deals of the Month 66
7.4 Pharmaceuticals & Healthcare, Rest of the World, Deals, February 2013 67
7.4.1 Rest of the World – Deals of the Month 68
8 Pharmaceuticals & Healthcare, Global, Top Financial Advisors 69
8.1 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, M&A, September 2012 – February 2013 69
8.2 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, Equity Offerings, September 2012 – February 2013 70
9 Further Information 71
9.1 Methodology 71
9.2 About GlobalData 71
9.3 Contact Us 72
9.4 Disclosure information 72
9.5 Disclaimer 72


【レポート販売概要】

■ タイトル:事業提携・ライセンシング・投資・M&A動向:February 2013(製薬業界)
■ 英文:Partnerships, Licensing, Investments and M&A Deals and Trends for February 2013 in Pharmaceuticals
■ 発行日:2013年3月12日
■ 調査会社:GlobalData
■ 商品コード:GDATA403160588
■ 調査対象地域:グローバル
  • 2014年戦略提言:ヨーロッパの臨床化学・免疫診断市場
    Complete report $19,700.  DataPack (test volumes, sales forecasts, supplier shares) $12,800. "2014 Strategies for the European Clinical Chemistry and Immunodiagnostic Market” is a new five-country strategic analysis of major business opportunities emerging in the clinical chemistry and immunodiagnostic markets during the next five years.  The report explores future trends …
  • メシフランの世界市場分析:用途別(食品・飲料、医薬品、動物用飼料)、地域別(北アメリカ、ヨーロッパ、アジア太平洋、中南米、MEA)、競争戦略、セグメント予測、2014-2025
    The global mesifurane market is expected to reach USD 153.8 million by 2025, according to a new report by Grand View Research, Inc. Inclination of consumers towards high-quality processed foods in emerging economies such as India and China is likely to boost demand for fresh and aromatic food additives such as mesifurane. The compound occurs naturally in fruits such as strawberries, and has a stro …
  • Chesapeake Energy Corporation社の石油・ガス開発・生産動向及びコスト分析(2013年第4四半期)
    Chesapeake Energy Corporation Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2013 Summary Chesapeake Energy Corporation Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an …
  • 結腸ステントのアメリカ市場:ニチノール自己拡張型金属ステント(SEMS)、エルジロイ(自己拡張型金属ステント(SEMS))
    The U.S. colonic stents market was valued at $6.44 million in 2018 and is projected to reach $9.41 million by 2026, registering a CAGR of 4.8% from 2019 to 2026. A colonic stent is used to relieve acute colonic obstruction in colorectal cancer patients. The stent is compressed tightly onto a small delivery wire that allows the stent to be positioned across the tight narrowing to relieve blockage i …
  • 世界の自動ソフトウェア品質管理市場動向(2012-2016)
    TechNavio's analysts forecast the Global Automated Software Quality market to grow at a CAGR of 6.27 percent over the period 2012-2016. One of the key factors contributing to this market growth is the need for enterprises to increase productivity. The Global Automated Software market has also been witnessing an increasing number of mergers and acquisitions. However, the lack of skilled resources c …
  • 宅配便・速達便・小包(CEP)の世界市場2016-2020
    About CEP CEP services include the delivery of parcels and documents to different types of customers such as business customers, retail customers, and government agencies. The parcels and documents delivered by the CEP vendors are non-palletized items, which usually weigh less than 110 pounds. The global CEP market is at a growing stage. This is attributable to the increased demand from e-commerce …
  • スマート包装の世界市場:インテリジェント、MAP、CAP、ガススカベンジャー、腐食/湿度制御
    Visiongain’s comprehensive new 232 page report reveals that the global smart packaging market will achieve revenues of $30.7bn in 2015 Are you involved in the smart packaging market or intend to be? If so, then you must read this report It’s vital that you keep your knowledge up to date. You need this report. Market scope: Smart packaging has multiple applications in food, beverage, pharmaceutical …
  • 世界のCO2レーザー(炭酸ガスレーザー)市場(2014-2018)
    About CO2 Lasers CO2 lasers contain an active laser medium, which is a gas discharge. CO2 lasers are preferred over other lasers such as excimer lasers primarily because they are more reliable, efficient, robust, and easier to operate than other lasers. They are mainly used for cutting and welding in industries such as Manufacturing, Automotive, Electronics, Healthcare, and Telecommunications beca …
  • 世界のヘルスケアITアウトソーシング市場
    Outsourcing is an emerging phenomenon in the healthcare information technology market. It is a screening process wherein an organization selects the most efficient third-party service provider to effectively operate its management and administrative unit. Outsourcing of IT solutions in the healthcare industry has emerged as an efficient solution to mitigate rising healthcare costs and to meet the …
  • 世界のIoNT(Internet of Nano Things)市場:通信種類別/ナノデバイス別/産業別分析
    The interconnectivity of nanoscale devices with deployed Internet networks has become the centre of all business activities; this is described as Internet of Nano Things (IoNT). It is the essence of smart connectivity of devices implemented for communication. It will help in seamless transfer of data among the devices with the help of a given spectrum. The internetwork of devices will change over …
  • インターフェロンの世界市場及びパイプライン分析
    Interferons are small, low molecular weight proteins of varying sizes induced during attack by infectious agents like viruses. Investigators have found that they are highly variable in nature and have several subtypes due to which misunderstanding is easily created. Furthermore, they have synergistic effect in which interferons belonging to different classes have same effect on immune system due t …
  • 世界主要国における狂犬病検査市場2015
    The report presents a detailed analysis of the Rabies diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Rabies definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market segments:     - Hospitals     - Commercial …
  • 乗用車用ホイールの世界市場2018-2022
    About Passenger Vehicle Wheels A wheel is a circular component that is intended to rotate on an axle bearing. Wheels in cars have tires and a rim, which are used to propel a vehicle. Technavio’s analysts forecast the Global Passenger Vehicle Wheels Market to grow at a CAGR of 7.53% during the period 2018-2022. Covered in this report The report covers the present scenario and the growth prospects o …
  • ソリッドコントロール装置の世界市場2015-2022
    According to Stratistics MRC, the Global Solid control equipment Market is valued at $1.84 billion in 2015 and is expected to grow at a CAGR of 11.41% to reach $3.92 billion by 2022. The rising demand for energy and increasing environmental concerns are the key factors driving the solids control equipment market growth. However adverse weather conditions pose a major challenge for the vendors in t …
  • 中国の飼料用プレミックス市場予測
    The Chinese feed premix market is projected to grow at a CAGR of 4.5% from 2016 to 2021. The feed premix market is projected to grow steadily due to the increasing importance for animal health, especially from the meat industry. Along with this, factors such as increasing demand for livestock products and rising awareness about animal health & animal feed quality are driving the feed premix market …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。